Customer Relationship Management Market PPT: Demand, Trends and Business Opportunities 2023-28 (1)

1
Global Continuous Glucose Monitoring Systems
Market Research and Forecast Report 2023-2028




Author Elena Anderson, Marketing Manager
IMARC Group
Copyright IMARC Service Pvt Ltd. All Rights
Reserved
2019 IMARC All Rights Reserved
2
About IMARC Group
Report Description
The International Market Analysis Research and
Consulting Group is a leading adviser on
management strategy and market research
worldwide. We partner with clients in all sectors
and regions to identify their highest-value
opportunities, address their most critical
challenges, and transform their
businesses. IMARCs information products include
major market, scientific, economic and
technological developments for business leaders
in pharmaceutical, industrial, and high
technology organizations. Market forecasts and
industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel
and tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3
Report Description and Highlights
Report Description
Global Continuous Glucose Monitoring Systems
Market Research Report The latest report by
IMARC, titled Continuous Glucose Monitoring
Systems Market Global Industry Trends, Share,
Size, Growth, Opportunity and Forecast 2023-2028
" the global continuous glucose monitoring
systems market size reached US 6.1 Billion in
2022. Continuous glucose monitoring systems
(CGMS) are medical devices that track blood
glucose levels throughout the day using small
sensors inserted under the skin. They consist of
sensors, transmitters, and receivers to collect,
measure, and display glucose level data. CGMS aid
in monitoring glucose trends over time by
providing valuable information at crucial points,
such as before and during exercise and in the
middle of the night. These devices also offer a
complete diabetes profile, detect patterns, and
evaluate and measure the effects of diet,
medications, and physical activity on sugar
levels, thus reducing the chances of
hypo/hyperglycemia. As compared to conventional
glucose monitoring machines, CGMS are painless
and minimize the number of finger-prick tests, as
it uses interstitial fluid to measure glucose
levels instead of blood. Request Free Sample
Report https//www.imarcgroup.com/continuous-gluc
ose-monitoring-systems-market/requestsample
4
Report Description and Highlights
Report Description

Global Continuous Glucose Monitoring Systems
Market Trends The rising prevalence of diabetes
due to sedentary lifestyles and obesity is one of
the primary factors driving the market growth.
CGMS is widely used to track glucose levels in
real-time, which aids in determining the
effectiveness of treatment plans and allows
patients to make more informed decisions
regarding physical activity, a balanced diet, and
medications. Furthermore, rising product adoption
among patients using intensive insulin therapy to
improve glycemic control, reduce the occurrence
of hypoglycemia events, and assist in tailoring
the insulin doses to improve hemoglobin A1c
(HbA1c) levels is creating a positive outlook for
the market. Additionally, the integration of
artificial intelligence (AI) to develop a
decision support system that provides advanced
diabetes management through personalized insulin
bolus calculation, adaptive tuning of bolus
calculator parameters, and glucose prediction is
providing an impetus to the market growth.
Moreover, the implementation of various
government initiatives to manage diabetes at a
larger scale and spread awareness regarding
preventive care measure is facilitating the
market growth. Other factors, including rising
health consciousness among consumers, extensive
research and development (RD) activities, and
easy product availability across various
e-commerce platforms, are anticipated to drive
the market growth. On account of the
aforementioned factors, the market value is
expected to reach US 8.6 Billion by 2028,
exhibiting a CAGR of 5.7 during
2023-2028. Looking forward, the market value is
projected to reach a strong growth during the
forecast period (2023-2028).
5
Report Description and Highlights
Report Description
Market Summary Breakup by Component S
ensors Transmitters and Receivers
Integrated Insulin Pumps Breakup by Demograph
ics Child Population (14 years)
Adult Population (gt14 years)
Breakup by End User Clinics and
Diagnostics Centers ICUs Home
Healthcare Breakup by Region North Ame
rica United States
Canada

6
Report Description and Highlights
Report Description
Asia-Pacific China
Japan India
South Korea Austral
ia Indonesia O
thers Europe Germany
France United K
ingdom Italy S
pain Russia Ot
hers Latin America B
razil Mexico
Others Middle East and Africa

7
Report Description and Highlights
Report Description

• Competitive Landscape with Key Players
• A. Menarini Diagnostics S.r.l. Abbott Laboratories
  DexCom Inc. F. Hoffmann-La Roche AG Glysens
  Incorporated LifeScan Inc. (Johnson Johnson) Med
  tronic PLC Medtrum Technologies Inc. Nemaura Medic
  al Inc. Novo Nordisk A/S Senseonics Holdings Inc.
  Waveform Technologies Inc.
• View Full Report with TOC List of Figure
  https//www.imarcgroup.com/continuous-glucose-moni
  toring-systems-market

8
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
9
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
10
Report Description and Highlights
Report Description

2019 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
11

Contact Us